{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T07:48:45Z","timestamp":1775807325763,"version":"3.50.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AR077565"],"award-info":[{"award-number":["R21AR077565"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AR079542"],"award-info":[{"award-number":["R21AR079542"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL158606"],"award-info":[{"award-number":["R01HL158606"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32AR007108"],"award-info":[{"award-number":["T32AR007108"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Neutrophil activation is heightened in inflammatory myopathies and associated with disease activity, yet its mechanisms remain unclear. This study explores the role of N-formyl methionine (fMET) in formyl peptide receptor 1 (FPR1)-mediated neutrophil activation in idiopathic inflammatory myopathies (IIMs), focusing on dermatomyositis (DM) and inclusion body myositis (IBM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Plasma from IBM (n\u2009=\u200946), DM (n\u2009=\u200940) and healthy controls (n\u2009=\u200940) was analysed for fMET, calprotectin, neutrophil elastase DNA (NE-DNA) and cytokines using ELISA. Neutrophil markers CD11b and CD66b were assessed by flow cytometry following plasma stimulation with or without FPR1 inhibition. Correlation analyses were performed between fMET, muscle strength (MMT8) and neutrophil activation markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>DM and IBM patients had significantly higher plasma fMET levels than controls (P\u2009&amp;lt;\u20090.0001 for DM; P\u2009=\u20090.0002 for IBM). Median fMET levels were 13\u2009719\u2009pg\/ml (75th percentile: 17\u2009236\u2009pg\/ml) for IBM, 14\u2009780\u2009pg\/ml (75th percentile: 17\u2009631\u2009pg\/ml) for DM and 8449\u2009pg\/ml (75th percentile: 12\u2009632\u2009pg\/ml) for controls. fMET correlated inversely with MMT8 in antibody-negative IBM (r\u2009=\u2009\u22120.53, P\u2009=\u20090.02). Calprotectin was elevated in DM (P\u2009=\u20090.01) but not IBM; NE-DNA complexes were increased in both DM (P\u2009=\u20090.03) and IBM (P\u2009&amp;lt;\u20090.0001). FPR1 inhibition significantly reduced plasma-induced neutrophil activation in DM (P\u2009&amp;lt;\u20090.0001) and IBM (P\u2009=\u20090.0012), restoring CD66b and partially CD11b to control levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings show that fMET-FPR1 signalling drives neutrophil activation in DM and IBM, promoting inflammation and muscle damage. Targeting this pathway may offer a novel IIM therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf495","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T11:53:12Z","timestamp":1757677992000},"source":"Crossref","is-referenced-by-count":1,"title":["N-formyl methionine peptide-driven neutrophil activation in idiopathic inflammatory myopathies"],"prefix":"10.1093","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5231-2469","authenticated-orcid":false,"given":"Jorge A","family":"Gonzalez-Chapa","sequence":"first","affiliation":[{"name":"Division of Rheumatology, University of Washington , Seattle, WA,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Begum","family":"Horuluoglu","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet , Stockholm,","place":["Sweden"]},{"name":"Center for Molecular Medicine, Karolinska Institutet , Stockholm,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Notarnicola","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet , Stockholm,","place":["Sweden"]},{"name":"Center for Molecular Medicine, Karolinska Institutet , Stockholm,","place":["Sweden"]},{"name":"Karolinska University Hospital, Department of Gastro, Dermatology and Rheumatology, Theme Inflammation and Aging , Stockholm,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arpit","family":"Rathee","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, University of Washington , Seattle, WA,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noor","family":"Kaur","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, University of Washington , Seattle, WA,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan D","family":"Stultz","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, University of Washington , Seattle, WA,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7150-7306","authenticated-orcid":false,"given":"Lisa","family":"Christopher-Stine","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Johns Hopkins University School of Medicine , Baltimore, Maryland,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8030-9504","authenticated-orcid":false,"given":"Jemima","family":"Albayda","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Johns Hopkins University School of Medicine , Baltimore, Maryland,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inger","family":"Nennesmo","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cancer Diagnostics, Karolinska University Hospital , Stockholm,","place":["Sweden"]},{"name":"Department of Oncology-Pathology, Karolinska Institutet , Stockholm,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6068-9212","authenticated-orcid":false,"given":"Ingrid E","family":"Lundberg","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet , Stockholm,","place":["Sweden"]},{"name":"Center for Molecular Medicine, Karolinska Institutet , Stockholm,","place":["Sweden"]},{"name":"Karolinska University Hospital, Department of Gastro, Dermatology and Rheumatology, Theme Inflammation and Aging , Stockholm,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6171-1952","authenticated-orcid":false,"given":"Christian","family":"Lood","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, University of Washington , Seattle, WA,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"2026020205392022100_keaf495-B1","doi-asserted-by":"crossref","first-page":"322","DOI":"10.7861\/clinmedicine.17-4-322","article-title":"Idiopathic inflammatory myopathies\u2014a guide to subtypes, diagnostic approach and treatment","volume":"17","author":"Oldroyd","year":"2017","journal-title":"Clin Med"},{"key":"2026020205392022100_keaf495-B2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/imj.15358","article-title":"Idiopathic inflammatory myopathies: a review","volume":"51","author":"Ashton","year":"2021","journal-title":"Intern Med J"},{"key":"2026020205392022100_keaf495-B3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.21037\/atm-20-5175","article-title":"Dermatomyositis autoantibodies: how can we maximize utility?","volume":"9","author":"Hodgkinson","year":"2021","journal-title":"Ann Transl Med"},{"key":"2026020205392022100_keaf495-B4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/1744666X.2022.2054803","article-title":"Complement in autoimmune inflammatory myopathies, the role of myositis-associated antibodies, COVID-19 associations, and muscle amyloid deposits","volume":"18","author":"Dalakas","year":"2022","journal-title":"Expert Rev Clin Immunol"},{"key":"2026020205392022100_keaf495-B5","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.4049\/jimmunol.0803688","article-title":"T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells1","volume":"183","author":"Fasth","year":"2009","journal-title":"J Immunol"},{"key":"2026020205392022100_keaf495-B6","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4103\/0019-5154.100486","article-title":"Clinical presentation and evaluation of dermatomyositis","volume":"57","author":"Marvi","year":"2012","journal-title":"Indian J Dermatol"},{"key":"2026020205392022100_keaf495-B7","doi-asserted-by":"crossref","first-page":"1020113","DOI":"10.3389\/fneur.2022.1020113","article-title":"Inclusion body myositis: update on the diagnostic and therapeutic landscape","volume":"13","author":"Naddaf","year":"2022","journal-title":"Front Neurol"},{"key":"2026020205392022100_keaf495-B8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0960-8966(00)00219-4","article-title":"Rimmed vacuoles and the added value of SMI-31 staining in diagnosing sporadic inclusion body myositis","volume":"11","author":"van der Meulen","year":"2001","journal-title":"Neuromuscul Disord NMD"},{"key":"2026020205392022100_keaf495-B9","doi-asserted-by":"crossref","first-page":"e134189","DOI":"10.1172\/jci.insight.134189","article-title":"Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies","volume":"5","author":"Seto","year":"2020","journal-title":"JCI Insight"},{"key":"2026020205392022100_keaf495-B10","doi-asserted-by":"crossref","first-page":"1113214","DOI":"10.3389\/fimmu.2023.1113214","article-title":"Inflammatory myopathies and beyond: the dual role of neutrophils in muscle damage and regeneration","volume":"14","author":"Torres-Ruiz","year":"2023","journal-title":"Front Immunol"},{"key":"2026020205392022100_keaf495-B11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10238-024-01384-2","article-title":"Pathogenic role and clinical significance of neutrophils and neutrophil extracellular traps in idiopathic inflammatory myopathies","volume":"24","author":"Liu","year":"2024","journal-title":"Clin Exp Med"},{"key":"2026020205392022100_keaf495-B12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/cei.12319","article-title":"Enhanced formation and impaired degradation of neutrophil extracellular traps in dermatomyositis and polymyositis: a potential contributor to interstitial lung disease complications","volume":"177","author":"Zhang","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"2026020205392022100_keaf495-B13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41423-021-00832-3","article-title":"Neutrophils in chronic inflammatory diseases","volume":"19","author":"Herrero-Cervera","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"2026020205392022100_keaf495-B14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13075-018-1632-x","article-title":"The roles of neutrophil serine proteinases in idiopathic inflammatory myopathies","volume":"20","author":"Gao","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2026020205392022100_keaf495-B15","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/art.41078","article-title":"Neutrophil extracellular traps in tissue and periphery in juvenile dermatomyositis","volume":"72","author":"Duvvuri","year":"2020","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"2026020205392022100_keaf495-B16","doi-asserted-by":"crossref","first-page":"103063","DOI":"10.1016\/j.jaut.2023.103063","article-title":"Molecular signature of neutrophil extracellular trap mediating disease module in idiopathic inflammatory myopathy","volume":"138","author":"Moon","year":"2023","journal-title":"J Autoimmun"},{"key":"2026020205392022100_keaf495-B17","doi-asserted-by":"crossref","first-page":"1001025","DOI":"10.3389\/fimmu.2022.1001025","article-title":"From bench to bedside: calprotectin (S100A8\/S100A9) as a biomarker in rheumatoid arthritis","volume":"13","author":"Inciarte-Mundo","year":"2022","journal-title":"Front Immunol"},{"key":"2026020205392022100_keaf495-B18","first-page":"3233","article-title":"Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8\/A9 induce neutrophil chemotaxis and adhesion","volume":"170","author":"Ryckman","year":"2003","journal-title":"J Immunol Baltim Md 1950"},{"key":"2026020205392022100_keaf495-B19","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1038\/s41467-022-32822-y","article-title":"Structural basis for recognition of N-formyl peptides as pathogen-associated molecular patterns","volume":"13","author":"Chen","year":"2022","journal-title":"Nat Commun"},{"key":"2026020205392022100_keaf495-B20","doi-asserted-by":"crossref","first-page":"2218077","DOI":"10.1080\/21505594.2023.2218077","article-title":"Mitochondrial N-formyl methionine peptides contribute to exaggerated neutrophil activation in patients with COVID-19","volume":"14","author":"R","year":"2023","journal-title":"Virulence"},{"key":"2026020205392022100_keaf495-B21","doi-asserted-by":"crossref","first-page":"785275","DOI":"10.3389\/fimmu.2021.785275","article-title":"N-Formyl methionine peptide-mediated neutrophil activation in systemic sclerosis","volume":"12","author":"Kuley","year":"2022","journal-title":"Front Immunol"},{"key":"2026020205392022100_keaf495-B22","doi-asserted-by":"crossref","first-page":"102630","DOI":"10.1016\/j.jaut.2021.102630","article-title":"Mitochondrial N-formyl methionine peptides associate with disease activity as well as contribute to neutrophil activation in patients with rheumatoid arthritis","volume":"119","author":"B","year":"2021","journal-title":"J Autoimmun"},{"key":"2026020205392022100_keaf495-B23","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13075-022-02849-z","article-title":"Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis","volume":"24","author":"D","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"2026020205392022100_keaf495-B24","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/s41591-021-01441-3","article-title":"Mitochondrial DNA variants modulate N-formylmethionine, proteostasis and risk of late-onset human diseases","volume":"27","author":"Cai","year":"2021","journal-title":"Nat Med"},{"key":"2026020205392022100_keaf495-B25","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature08780","article-title":"Circulating mitochondrial DAMPs cause inflammatory responses to injury","volume":"464","author":"Zhang","year":"2010","journal-title":"Nature"},{"key":"2026020205392022100_keaf495-B26","doi-asserted-by":"crossref","first-page":"103308","DOI":"10.1016\/j.autrev.2023.103308","article-title":"Oxidative stress, mitochondrial dysfunction, and respiratory chain enzyme defects in inflammatory myopathies","volume":"22","author":"Danieli","year":"2023","journal-title":"Autoimmun Rev"},{"key":"2026020205392022100_keaf495-B27","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00401-008-0449-0","article-title":"Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer and Parkinson disease brains","volume":"116","author":"Askanas","year":"2008","journal-title":"Acta Neuropathol (Berl"},{"key":"2026020205392022100_keaf495-B28","doi-asserted-by":"crossref","first-page":"103332","DOI":"10.1016\/j.jaut.2024.103332","article-title":"Autoantibodies against a subunit of mitochondrial respiratory chain complex I in inclusion body myositis","volume":"149","author":"Notarnicola","year":"2024","journal-title":"J Autoimmun"},{"key":"2026020205392022100_keaf495-B29","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1073\/pnas.94.2.514","article-title":"Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative\u2009stress","volume":"94","author":"Yakes","year":"1997","journal-title":"Proc Natl Acad Sci"},{"key":"2026020205392022100_keaf495-B30","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41419-024-06863-8","article-title":"mtDNA release promotes cGAS-STING activation and accelerated aging of postmitotic muscle cells","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis"},{"key":"2026020205392022100_keaf495-B31","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/rheumatology\/kead654","article-title":"The emerging role of Growth Differentiation Factor 15 as a potential disease biomarker in juvenile dermatomyositis","volume":"64","author":"Duvvuri","year":"2025","journal-title":"Rheumatol Oxf Engl"},{"key":"2026020205392022100_keaf495-B32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mito.2019.10.005","article-title":"Growth and differentiation factor 15 as a biomarker for mitochondrial myopathy","volume":"50","author":"Poulsen","year":"2020","journal-title":"Mitochondrion"},{"key":"2026020205392022100_keaf495-B33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nm.4027","article-title":"Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease","volume":"22","author":"Lood","year":"2016","journal-title":"Nat Med"},{"key":"2026020205392022100_keaf495-B34","volume-title":"A practical approach","author":"Dubowitz","year":"2021","edition":"5th ed"},{"key":"2026020205392022100_keaf495-B35","first-page":"668","article-title":"Formyl-peptide receptor activation enhances phagocytosis of community-acquired methicillin-resistant staphylococcus aureus","volume":"221","author":"Wei\u00df","year":"2020","journal-title":"J Infect Dis"},{"key":"2026020205392022100_keaf495-B36","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3389\/fimmu.2018.00536","article-title":"Mitochondria: an organelle of bacterial origin controlling inflammation","volume":"9","author":"Meyer","year":"2018","journal-title":"Front Immunol"},{"key":"2026020205392022100_keaf495-B37","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1126\/science.1195491","article-title":"Intravascular danger signals guide neutrophils to sites of sterile inflammation","volume":"330","author":"McDonald","year":"2010","journal-title":"Science"},{"key":"2026020205392022100_keaf495-B38","doi-asserted-by":"crossref","first-page":"e0006","DOI":"10.5041\/RMMJ.10493","article-title":"The emerging role of mitochondrial dysfunction in the pathogenesis of idiopathic inflammatory myopathies","volume":"14","author":"Gonzalez-Chapa","year":"2023","journal-title":"Rambam Maimonides Med J"},{"key":"2026020205392022100_keaf495-B39","doi-asserted-by":"crossref","first-page":"103061","DOI":"10.1016\/j.jaut.2023.103061","article-title":"Role of mitochondria in the myopathy of juvenile dermatomyositis and implications for skeletal muscle calcinosis","volume":"138","author":"Duvvuri","year":"2023","journal-title":"J Autoimmun"},{"key":"2026020205392022100_keaf495-B40","first-page":"5","article-title":"Emerging Roles of GDF-15 in Immunoregulation and Pathogenesis","volume":"210","author":"Reyes","year":"2023","journal-title":"J Immunol Baltim Md 1950"},{"key":"2026020205392022100_keaf495-B41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1084\/jem.20180448","article-title":"The gut microbiome: relationships with disease and opportunities for therapy","volume":"216","author":"Durack","year":"2019","journal-title":"J Exp Med"},{"key":"2026020205392022100_keaf495-B42","first-page":"100046","article-title":"Influence of gut microbiota on autoimmunity: a narrative review","volume":"5","author":"Sai","year":"2024","journal-title":"Brain Behav Immun Integr"},{"key":"2026020205392022100_keaf495-B43","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2337\/db18-1307","article-title":"Microbiota-Produced N-Formyl Peptide fMLF promotes obesity-induced glucose intolerance","volume":"68","author":"Wollam","year":"2019","journal-title":"Diabetes"},{"key":"2026020205392022100_keaf495-B44","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ncl.2014.04.001","article-title":"Inclusion body myositis","volume":"32","author":"Dimachkie","year":"2014","journal-title":"Neurol Clin"},{"key":"2026020205392022100_keaf495-B45","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/cells11020236","article-title":"S100A8\/A9 is a marker for the release of neutrophil extracellular traps and induces neutrophil activation","volume":"11","author":"Sprenkeler","year":"2022","journal-title":"Cells"},{"key":"2026020205392022100_keaf495-B46","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/1753425919848476","article-title":"The time course of calprotectin liberation from human neutrophil granulocytes after Escherichia coli and endotoxin challenge","volume":"25","author":"Lipcsey","year":"2019","journal-title":"Innate Immun"},{"key":"2026020205392022100_keaf495-B47","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/ijms22020559","article-title":"Neutrophil extracellular traps and their implications in cardiovascular and inflammatory disease","volume":"22","author":"Klopf","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026020205392022100_keaf495-B48","doi-asserted-by":"crossref","first-page":"e1000639","DOI":"10.1371\/journal.ppat.1000639","article-title":"Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against candida albicans","volume":"5","author":"Urban","year":"2009","journal-title":"PLoS Pathog"},{"key":"2026020205392022100_keaf495-B49","doi-asserted-by":"crossref","first-page":"e0167529","DOI":"10.1371\/journal.pone.0167529","article-title":"Formylated MHC class Ib binding peptides activate both human and mouse neutrophils primarily through formyl peptide receptor 1","volume":"11","author":"Winther","year":"2016","journal-title":"PLOS ONE"},{"key":"2026020205392022100_keaf495-B50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/BOR.0000000000000979","article-title":"New therapies in anti-MDA5 antibody-positive dermatomyositis","volume":"36","author":"Yasui","year":"2024","journal-title":"Curr Opin Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf495\/64273385\/keaf495.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/1\/keaf495\/64273385\/keaf495.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/1\/keaf495\/64273385\/keaf495.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T10:39:35Z","timestamp":1770028775000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/doi\/10.1093\/rheumatology\/keaf495\/8254283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,8]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf495","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,9,15]]},"article-number":"keaf495"}}